View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

GigaCloud Technology Inc: 1 director

A director at GigaCloud Technology Inc sold 189,998 shares at 37.127USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

Energia Innovacion Y Desarrollo Fotovoltaicos S.A.: 1 director

A director at Energia Innovacion Y Desarrollo Fotovoltaicos S.A. bought 78,423 shares at 6.532EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...

Pluxee N.V.: 1 director

A director at Pluxee N.V. sold 5,000 shares at 31.100EUR and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Paycom Software Inc: 1 director

A director at Paycom Software Inc sold 3,900 shares at 180.825USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

Arista Networks Inc: 2 directors

Two Directors at Arista Networks Inc sold/gave away 40,716 shares at between 0.000USD and 327.000USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's direc...

BGSF Inc: 1 director

A director at BGSF Inc bought 6,000 shares at 6.760USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

ABGSC Shipping & Transport Research ... (+3)
  • ABGSC Shipping & Transport Research
  • Oliver Dunvold
  • Petter Haugen

Outperformance ahead

Q2'24 estimates up on strong guidance - continues to outperform. ABGSCe ‘25 EBITDA 46% above cons. TP of NOK 449 (427) – BUY.

Altair Engineering Inc: 2 directors

Three Directors at Altair Engineering Inc sold 52,457 shares at between 90.102USD and 91.080USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...

Raketech Group Holding: 1 director

A director at Raketech Group Holding bought 83,330 shares at 12.080SEK and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

 PRESS RELEASE

Sydbank A/S køber Coop Bank A/S

Sydbank A/S køber Coop Bank A/S Selskabsmeddelelse nr. 18/2024Peberlyk 4DK-6200 AabenraaTelefon Sydbank A/SCVR-nr. DK 12626509, Aabenraasydbank.dk21. maj 2024  Sydbank A/S køber Coop Bank A/S Sydbank A/S og Coop amba har indgået aftale om, at Sydbank køber Coop Bank A/S. Efter overtagelsen vil Coop Bank A/S være et 100 pct. ejet datterselskab af Sydbank A/S. Aftalen omfatter også et partnerskab, der vil skabe attraktive værditilbud for såvel kunderne i Coop Bank A/S og Coop Danmarks øvrige medlemmer. Partnerskabet forventes at kunne give øget forretningsomfang i Coop Bank A/S. Kø...

 PRESS RELEASE

Sydbank to acquire Coop Bank A/S

Sydbank to acquire Coop Bank A/S Company Announcement No 18/2024Peberlyk 46200 AabenraaDenmarkTel Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk21 May 2024  Dear Sirs Sydbank to acquire Coop Bank A/S Sydbank A/S and Coop amba have concluded an agreement to the effect that Sydbank will acquire Coop Bank A/S. Following the acquisition, Coop Bank A/S will become a wholly owned subsidiary of Sydbank A/S. In addition the agreement includes a partnership that will create attractive value propositions for the customers of Coop Bank A/S as well as for the other members of Coop Danmark...

Maria Vara
  • Maria Vara

ONWARD: Up-LIFT reveals ARC-EX extraordinary neurological potential vs...

The so-awaited full disclosure of the ARC-EX Up-LIFT pivotal study materialized yesterday with its publication in the top-tier scientific journal - Nature (access here). Whilst the top-line data reported in April 2023 already validated ARC-EX Therapy efficacy hitting 72% responder rate, the extende

Braze Inc: 2 directors

Two Directors at Braze Inc sold after exercising options/sold 32,111 shares at between 41.762USD and 42.680USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the compa...

Boom Logistics Limited: 1 director

A director at Boom Logistics Limited bought 500,000 shares at 0.138AUD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

MeiHua Holdings Group Co Ltd: 3 directors

Three Directors at MeiHua Holdings Group Co Ltd bought 913,800 shares at between 11.220CNY and 11.230CNY. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...

Kuwait International Bank: 2 directors

Two Directors at Kuwait International Bank sold/bought 3,711,094 shares at between 0.176KWD and 0.178KWD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...

Worldline SA: 1 director

A director at Worldline SA maiden bought 5,000 shares at 11.750EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Pierre François Merveille
  • Pierre François Merveille

Teva : New products support return to growth

2023 has been a transition year for Teva with the appointment of a new CEO at the beginning of the year and the launch of the “Pivot To Growth” strategy. The group returned to positive revenue growth last year but profitability was hit on an underlying basis by commercial and R&D efforts. Teva should start to bear fruits from its growth initiatives this year with underlying growth adjusted for the upfront payment from Sanofi in 2023. Austedo and Ajovy revenues are increasing at ...

Political risk – Europe: EU Parliament elections provide continuity as...

The centrist grand coalition that has passed most key EU legislation in the last five years looks set to retain its working majority. But fewer green-left seats could limit climate ambitions

Pierre François Merveille
  • Pierre François Merveille

Teva : New products support return to growth

2023 has been a transition year for Teva with the appointment of a new CEO at the beginning of the year and the launch of the “Pivot To Growth” strategy. The group returned to positive revenue growth last year but profitability was hit on an underlying basis by commercial and R&D efforts. Teva should start to bear fruits from its growth initiatives this year with underlying growth adjusted for the upfront payment from Sanofi in 2023. Austedo and Ajovy revenues are increasing at d...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch